COMPASS Pathways plc financial data

Symbol
CMPS on Nasdaq
Industry
Pharmaceutical Preparations
Location
3 Rd Floor, 1 Ashley Road, Altrincham, Chesire, United Kingdom
State of incorporation
United Kingdom
Fiscal year end
December 31
Former names
Compass Rx Ltd. (to 8/10/2020)
Latest financial report
10-Q - Q3 2024 - Oct 31, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.21K % -20.6%
Debt-to-equity 22.9 % +49.1%
Return On Equity -63.8 % -4.16%
Return On Assets -52 % +2.22%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 68.4M shares +10.5%
Common Stock, Shares, Outstanding 68.4M shares
Entity Public Float 216M USD -12.7%
Common Stock, Value, Issued 699K USD
Weighted Average Number of Shares Outstanding, Basic 68.4M shares +37.8%
Weighted Average Number of Shares Outstanding, Diluted 68.4M shares +37.8%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 114M USD +42.2%
General and Administrative Expense 54.2M USD +7.18%
Operating Income (Loss) -168M USD -28.7%
Nonoperating Income (Expense) 24.8M USD +73.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -143M USD -23.2%
Income Tax Expense (Benefit) 965K USD +102%
Net Income (Loss) Attributable to Parent -144M USD -23.5%
Earnings Per Share, Basic -2.13 USD/shares +17.8%
Earnings Per Share, Diluted -2.13 USD/shares +17.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 207M USD -16.6%
Other Assets, Current 1.78M USD -14.3%
Assets, Current 234M USD -18%
Deferred Income Tax Assets, Net 4.41M USD +29.6%
Property, Plant and Equipment, Net 359K USD -41.3%
Operating Lease, Right-of-Use Asset 2.75M USD -34.1%
Other Assets, Noncurrent 6.52M USD +10.9%
Assets 247M USD -17.3%
Accounts Payable, Current 8.23M USD +93.8%
Employee-related Liabilities, Current 3.12M USD +4.81%
Liabilities, Current 26.2M USD +70.8%
Operating Lease, Liability, Noncurrent 459K USD -77%
Liabilities 54.3M USD +18.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax -16.5M USD +5.29%
Retained Earnings (Accumulated Deficit) -491M USD -41.6%
Stockholders' Equity Attributable to Parent 193M USD -23.8%
Liabilities and Equity 247M USD -17.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -20.8M USD +24.9%
Net Cash Provided by (Used in) Financing Activities 63.5M USD +5786%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 68.4M shares
Common Stock, Shares, Issued 68.4M shares
Common Stock, Par or Stated Value Per Share 0.01 GBP/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 42.6M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 207M USD -16.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 765K USD
Deferred Tax Assets, Valuation Allowance 76.1M USD +46.5%
Deferred Tax Assets, Gross 79.5M USD +46.5%
Operating Lease, Liability 3.72M USD +144%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -143M USD -38.3%
Lessee, Operating Lease, Liability, to be Paid 3.99M USD +148%
Property, Plant and Equipment, Gross 1.15M USD +51.7%
Operating Lease, Liability, Current 2.3M USD +9.32%
Lessee, Operating Lease, Liability, to be Paid, Year Two 227K USD +1.79%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.81M USD +568%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure +33.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 274K USD +230%
Lessee, Operating Lease, Liability, to be Paid, Year Three 96K USD +74.5%
Deferred Tax Assets, Operating Loss Carryforwards 64.7M USD +46.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 95K USD +75.9%
Operating Lease, Payments 628K USD +11.7%
Additional Paid in Capital 700M USD +13.5%
Depreciation, Depletion and Amortization 61K USD +27.1%
Share-based Payment Arrangement, Expense 19.2M USD +17.3%
Interest Expense 1.1M USD